no its there

Thanks BioT, Misiu. My experience is when this kind of coverage is initiated it's usually been caused from institutional interest.
This could get interesting quickly.
Chump

Closet-So what can we look for tomorrow?
Your predictions please for the board.
Thanks
Chump

See you next week hopefully! Take care

The 31k at $1.06 is going down.
Chump

All these apps, TA, decimal trading what ever happen to going to the library and reading Value Line and Moody's.
Chump

d0lphintom- please post your TA's etc. Thanks!
Chump

Good point it just seems an endless supply on the ask and limited on the bid.

Anybody else have the feeling this is being walked down for accumulation not a sell off? Easily done on the OTC board.
Chump

tpiazz24- As I posted earlier I think they have enough to approach Institutions that "they're on their way" get your eye on us. A lot has progressed in the last few months. That's how I think CYDY needs to go about it.
For buying or selling everybody do their own thing. I'm not here to post to buy or sell.
Chump

I've posted it before for a big pharma to drop 30-40 mil to get CYDY through final trials ensuring an exclusive distribution for CYDY given it makes it's final pass is nothing as a gamble. They would be crazy not to try and lock something down. i think the ASM and Charlie tooting it up only helps. This is biz and how it works.
Folks talking bout passing pase ? or ? this is another ball game. Pro 140 is disruptive and will get the attention deserved.
Chump

Resumeblank- good question and i agree. My posts was that from a conversation with an institutional investor closely watching CYDY. Exposure from the ASM pres vs competitive pharmas, new exposure with the best data results for HIV in trials currently , possible exclusive licensing with a big pharma, possible BTD, Orphan status etc. could get it over $2 very quickly without an R/S and allow them them to hop on board. I'm convinced they have enough to secure any of the above at any given day. If that happens a road show will put this sp where it should be. The OTC is the only thing holding us back. Here's to news soon.
Chump

I am to

rnoutlaw21, malamutus- Your entitled to what you think. Doesn't offend me or change what I posted. I never asked anyone to buy but was reassuring that what I was hearing was there's powder in the cannon.
Just revisit your posts next week unless you know different. I look forward to it. And based on todays prices many will wish they bought.
Chump

cydy wont go brick and-mortor. Partnership exclusivity licensing is there best option. I look for it.
Chump

5top- 100% agree. The company is not hurting for money, its hurting for long term investors that realize the disruptive opportunity of an investment that CYDY offers. It's catching on.
Chump

Dolphin0m- I'm sure you know this but institutions cant buy on the OTC under 5. If it gets to 2 cydy can up list in one day and institutions can buy from 2 up. With August 26 as there r/s deadline I think they have enough to organically get to 2 before that. Letting institutions know beforehand 2 is coming is like five elephants trying to get through the door at the same time. Imo a r/s will not happen. Give it a week and let's see what they have from the FDA or partnership. ASM was a big success. Institutional investors follow it. IMO week of july 11th will be very good for CYDY.
Chump

tootalljones- I expect a double before that. Someone correct me if I'm wrong but I think CYDY has until August 26th to r/s if needed. What I'm hearing is that a r/s won't be needed. Why, BTD and orphan status could come any day based on what the FDA required, partnership which Dr P said in his interview eluded to etc. interested institutions from the ASM presentation. Next week is holiday week many institutions off but the next week things could crank up. I think the week of the 11th will bring a rise in price.
Lots of exposure if you google Pro 140. IMO- I think this is a 5000lb boulder bout to slip off the cliff. Not trying to pump but CYDY has some amazing data results that are seriously needed for HIV treatment. I've always called CYDY's treatment as "disruptive" to whats currently available. There's plenty of value in CYDY vs the competition.
The FDA because of the results has to make this treatment more available.
There move!!
Chump

Thanks!

misiu143- your contributions to the board and myself for CYDY are priceless. You being a retired Dr having gone through many of the trials CYDY is going through and sharing your input is invaluable. You know what the FDA requires and the time lines they put on clinical trials and data they need.
Knowing you believe in the data and support CYDY is very reassuring. I don't skip any of your posts. Your very valuable to this board and thanks.
I will continue to reach out for your clinical input.
Here's to getting over $2 and getting to market a better HIV treatment.
Thanks
Chump

Thanks 5top your contributions to the board have been great, I read all of them. Nothing but good things ahead for CYDY. All good. All good!!
Chump

Wallstreet- I saw your post in reply to mine. Thanks for deleting it. It's ok, you're fine with me. I've been on different msg boards for 20+ years and someone always posts an out of the air pump post and it catches me the same way. It's not pump. I hope CYDY puts out a PR for they're road show next week. They have all the data, semi peer review from the ASM and 1st patient p3 injection, GV/HD orphan status in the works. Enough to get some institutions very interested in CYDY, which we need very badly. Let's get back in that hold pattern and see what happens. This is a good board with valuable contributors.
Chump

Safe as your mothers love!

Good news for the holders bad news for the sellers. Had a conversation with an institutional investor. CYDY is going on a road show to institutions next week because this bad boy is about to be over $2. Organically no R/S and the waiting institutions need to be aware.
No pump. Fact!
Chump

Closet- Your'e wrong. CYDY has first patient P3 injection /gvhd any day. And much exposure from the ASM to bring new opportunities. CYDY has covered in a few years what takes many others 20+. Cydy has a patient Charlie which is un heard of to have publicly claim it's working during the trials. It's building slowly. Watch the vol the next 10 days and re visit if it'a POS or in the 80-90's.
Chump

Let the sellers out it will turn around.

Charlie said his viral loads went from 7000 to almost undetectabale.
Nice

5top thanks!

Maybe the delay for a press is to allow ASM to publish in their journal first.

I read the same somewhere also

Nice post Titan next is the Today show Tues.

If we up list..watch the vol go way up.

I think their going to be in their next monthly journal.
Could be wrong a guess.
Chump

michelinvests-I agree the data to be presented at the ASM probably will be much that we already know, probably more in detail/clinical. Here's the plus side. The oral presentation CYDY is giving can only be accepted by invitation after submitting their abstract and they the peers at ASM review and approve it. CYDY had to be chosen for the oral presentation. CYDY isn't just having a booth there. They were selected exclusively because it caught their attention in high regards. Further because of the data they were chosen as the feature press release for the event. That alone speaks volumes from peers that CYDY's data was tops among the others and is something that needs to be shared as top for the event. This is exclusivity and most of all exposure that's valuable. Exposure that a lot of new peers will take strong interest in. Mostly the competition, GLD, Merck, Bristol etc. So my point is the opportunity to share their data at an event like this is the value for CYDY at the ASM. Separate exposure from the ASM is Charlie, a patient on the treatment telling the world the data is real cause I feel the best on this new treatment. It's all about exposure that will continue to build and ultimately drive new investors to CYDY. As for a r/s CYDY probably feels that the exposure will be the success of a r/s if needed.
Chump

I agree Piers Morgan interview Sunday, ASM monday and Today show Tues could get us there organically. I think we caught the OTC MM's by surprise Thursday. Hopefully they realize whats going on now and let it go its way Monday.
Chump

I don't think CYDY is relying just on the ASM exposure for $2. With P3 fist patient injections any day gv/hd and orphan status waiting on the FDA, and from the ASM exposure (peer review) a r/s split up list would be positive. They have a story and i think it's getting out in their favor. And again to have a patient like Charlie promoting the benefits from treatment only helps.
We have no institutions and an up list brings them aboard.
Chump

Or lock in an exclusive licensing deal for a little funding.

Agree A buy will go by at the ask and immediately a 100 share at the bid drops it.

lol We need to email and tweet Piers Morgan what treatment is Charlie on for HIV thats making him tell everyone he's feeling his best, migraines gone. Share it to all with HIV please! Whats this Pro 140?

From the TA folks here. What's the majic number we need to overcome,
$1.50?
Thanks